US4018653A
(en)
|
1971-10-29 |
1977-04-19 |
U.S. Packaging Corporation |
Instrument for the detection of Neisseria gonorrhoeae without culture
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4123524A
(en)
|
1977-06-08 |
1978-10-31 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl)pyrrolo[4,3,2-de]pyrimido[4,5-C]pyridazine-5'-phosphate as a novel compound and its utility against L-1210 mouse leukemia
|
DE2820893C2
(de)
|
1978-05-12 |
1986-02-20 |
A. Nattermann & Cie GmbH, 5000 Köln |
Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
|
US4444766A
(en)
|
1980-10-21 |
1984-04-24 |
Boehringer Mannheim Gmbh |
Sulfur-containing phospholipid compounds and therapeutic compositions
|
US4493832A
(en)
|
1981-07-03 |
1985-01-15 |
Fujisawa Pharmaceutical Co., Ltd. |
Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same
|
DE3264782D1
(en)
|
1981-10-16 |
1985-08-22 |
Sanol Arznei Schwarz Gmbh |
Medicinal formulation
|
US4562179A
(en)
|
1982-04-19 |
1985-12-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Phospholipid derivatives, and pharmaceutical composition of the same
|
US4424279A
(en)
|
1982-08-12 |
1984-01-03 |
Quidel |
Rapid plunger immunoassay method and apparatus
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
DE3323871A1
(de)
|
1983-07-02 |
1985-01-03 |
A. Nattermann & Cie GmbH, 5000 Köln |
Neue 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
US6448392B1
(en)
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US5019368A
(en)
|
1989-02-23 |
1991-05-28 |
Cancer Biologics, Inc. |
Detection of necrotic malignant tissue and associated therapy
|
ATE77947T1
(de)
*
|
1987-04-09 |
1992-07-15 |
Fisons Plc |
Pentamidin enthaltende pharmazeutische zusammensetzungen.
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
WO1989002733A1
(en)
|
1987-09-22 |
1989-04-06 |
The Regents Of The University Of California |
Liposomal nucleoside analogues for treating aids
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
US5817638A
(en)
|
1988-07-07 |
1998-10-06 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
US6252060B1
(en)
|
1988-07-07 |
2001-06-26 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
US5135736A
(en)
|
1988-08-15 |
1992-08-04 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
CA2001401A1
(en)
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
US5759837A
(en)
*
|
1989-01-17 |
1998-06-02 |
John Hopkins University |
Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
|
IL93925A0
(en)
|
1989-03-29 |
1990-12-23 |
Alcon Lab Inc |
Pharmaceutical compositions containing a monoacyl phosphogylceride
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
GR1000688B
(el)
|
1989-12-22 |
1992-10-08 |
Sod Conseils Rech Applic |
Μεθοδος παρασκευης παραγωγων γλυκερινης.
|
WO1991016920A1
(en)
|
1990-05-07 |
1991-11-14 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
WO1991018914A1
(en)
|
1990-05-29 |
1991-12-12 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
CA2083961A1
(en)
|
1990-05-29 |
1991-11-30 |
Henk Van Den Bosch |
Synthesis of glycerol di- and triphosphate derivatives
|
ES2083580T3
(es)
|
1990-06-13 |
1996-04-16 |
Arnold Glazier |
Profarmacos de fosforo.
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5798339A
(en)
*
|
1990-12-17 |
1998-08-25 |
University Of Manitoba |
Treatment method for cancer
|
WO1992017185A1
(en)
|
1991-03-29 |
1992-10-15 |
University Of Florida |
Targeted drug delivery via mixed phosphate derivatives
|
EP0594677A4
(en)
|
1991-07-12 |
1997-09-17 |
Vical Inc |
Antiviral liponucleosides: treatment of hepatitis b
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
DE69231487T2
(de)
|
1991-10-28 |
2001-03-01 |
Dennis L. Fost |
Phospholipid-antimikrobielle zusammensetzungen
|
US5976535A
(en)
|
1992-06-09 |
1999-11-02 |
Neorx Corporation |
Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
|
US5541287A
(en)
|
1992-06-09 |
1996-07-30 |
Neorx Corporation |
Pretargeting methods and compounds
|
US5512671A
(en)
|
1993-02-16 |
1996-04-30 |
Wake Forest University |
Ether lipid-nucleoside covalent conjugates
|
FR2703353B1
(fr)
*
|
1993-03-29 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés de la beta-phénylisosérine.
|
EP0746319A4
(en)
|
1993-05-12 |
1997-11-05 |
Karl Y Hostetler |
ACYCLOVIR DERIVATIVES FOR TOPICAL USE
|
ATE226437T1
(de)
|
1993-06-10 |
2002-11-15 |
Univ Wake Forest |
(phospho)lipide zum bekämpfen einer hepatitis b- infektion
|
CA2197319C
(en)
|
1994-08-29 |
2009-01-27 |
Louis S. Kucera |
Lipid analogs for treating viral infections
|
US7135584B2
(en)
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
CA2204902A1
(en)
|
1994-11-30 |
1996-06-06 |
Fred I. Chasalow |
Phosphocholine drug derivatives
|
US6177460B1
(en)
*
|
1995-04-12 |
2001-01-23 |
The Procter & Gamble Company |
Method of treatment for cancer or viral infections
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US5798374A
(en)
*
|
1995-06-07 |
1998-08-25 |
Sugen Inc. |
Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
|
US6388076B1
(en)
*
|
1995-06-19 |
2002-05-14 |
Ontogen Corporation |
Protein tyrosine phosphatase-inhibiting compounds
|
US6207145B1
(en)
*
|
1997-05-09 |
2001-03-27 |
Pharma Pacific Pty Ltd. |
Therapeutic applications of high dose interferon
|
CA2255615C
(en)
|
1996-05-22 |
2006-08-29 |
Neuromedica, Inc. |
Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6020179A
(en)
*
|
1996-10-03 |
2000-02-01 |
Incyte Pharmaceuticals, Inc. |
Nucleic acids encoding human tyrosine phosphatases
|
US6600028B1
(en)
*
|
1997-04-02 |
2003-07-29 |
Amersham Pharmacia Biotech Uk Limited |
Tricyclic base analogues
|
JPH1191623A
(ja)
|
1997-09-18 |
1999-04-06 |
Unisia Jecs Corp |
キャブサスペンション制御装置
|
US6262044B1
(en)
*
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
IN183330B
(lt)
*
|
1998-03-23 |
1999-11-20 |
Dalmia Ct For Biotechnology |
|
US6022029A
(en)
|
1998-06-19 |
2000-02-08 |
Yukiwa Seiko Kabushiki Kaisha |
Chuck assembly
|
US6013646A
(en)
|
1998-07-02 |
2000-01-11 |
Bayer Corporation |
Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
|
DE19845798A1
(de)
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
US6258582B1
(en)
*
|
1998-09-30 |
2001-07-10 |
Millennium Pharmaceuticals, Inc. |
CSAPTP nucleic acid molecules and uses therefor
|
WO2000021506A2
(en)
|
1998-10-13 |
2000-04-20 |
Mcgill University |
Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy
|
US6890904B1
(en)
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
CA2387351C
(en)
|
1999-10-19 |
2009-09-08 |
Merck & Co., Inc. |
Indole derivatives as tyrosine kinase inhibitors
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
BR0015436A
(pt)
|
1999-11-09 |
2002-07-16 |
Alcon Inc |
Sais de hidroxieicosatetraenoato, composições e métodos de uso no tratamento de distúrbios dos olhos secos
|
ES2327313T3
(es)
|
1999-11-16 |
2009-10-28 |
Oncozyme Pharma Inc. |
Pentamidina para el tratamiento del cancer.
|
JP4397503B2
(ja)
|
2000-03-30 |
2010-01-13 |
アスモ株式会社 |
回転電機のヨークの製造方法
|
WO2001074853A2
(en)
|
2000-04-03 |
2001-10-11 |
Massachusetts Institute Of Technology |
Methods and products for regulating cell motility
|
JP4317913B2
(ja)
|
2000-04-14 |
2009-08-19 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
Aktタンパク質発現の定量方法
|
JP5409981B2
(ja)
|
2000-05-15 |
2014-02-05 |
セルジーン コーポレイション |
癌治療用の組成物および方法
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6569853B1
(en)
*
|
2000-11-06 |
2003-05-27 |
Combinatorx, Incorporated |
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
|
JP4564714B2
(ja)
|
2000-11-27 |
2010-10-20 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法
|
US20020128228A1
(en)
|
2000-12-01 |
2002-09-12 |
Wen-Jen Hwu |
Compositions and methods for the treatment of cancer
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
WO2002053138A2
(en)
|
2001-01-02 |
2002-07-11 |
Elisabeth Shanahan-Prendergast |
Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
|
US6693125B2
(en)
*
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
WO2002069949A2
(en)
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
US6872733B2
(en)
|
2001-04-18 |
2005-03-29 |
Euro-Celtique S.A. |
Benzimidazolone compounds
|
DE60229736D1
(de)
|
2001-04-18 |
2008-12-18 |
Euro Celtique Sa |
Spiroinden- und spiroindan-verbindungen
|
BR0209127A
(pt)
|
2001-04-18 |
2006-03-21 |
Euro Celtique Sa |
compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
|
US20040072824A1
(en)
|
2001-06-01 |
2004-04-15 |
Adam Telerman |
Methods and compositions for the treatment of cancer
|
US20020197639A1
(en)
|
2001-06-08 |
2002-12-26 |
Shia Michael A. |
Methods and products for analyzing nucleic acids based on methylation status
|
US6955888B2
(en)
|
2001-06-11 |
2005-10-18 |
Xenoport |
Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
|
US20030119741A1
(en)
|
2001-11-09 |
2003-06-26 |
Rasmus Rojkjaer |
Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptides
|
US20040116462A1
(en)
|
2002-12-12 |
2004-06-17 |
Mitsunori Ono |
Indolizine compounds
|
US7098302B2
(en)
|
2001-10-12 |
2006-08-29 |
University Of Vermont And State Agricultural College |
Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
|
US20030119747A1
(en)
|
2001-11-01 |
2003-06-26 |
Lanser Marc E. |
Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor
|
AU2003224603A1
(en)
|
2002-01-22 |
2003-10-08 |
The Regents Of The University Of California |
Potentiation of cancer therapies by znf217 inhibition
|
JP2005533001A
(ja)
|
2002-03-04 |
2005-11-04 |
メディミューン,インコーポレーテッド |
インテグリンαvβ3アンタゴニストを他の物質と併用投与する癌の予防または治療方法
|
NZ535349A
(en)
|
2002-03-08 |
2007-01-26 |
Signal Pharm Inc |
JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular
|
US6962940B2
(en)
|
2002-03-20 |
2005-11-08 |
Celgene Corporation |
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
|
US6620838B1
(en)
|
2002-04-19 |
2003-09-16 |
Signal Pharmaceuticals, Inc. |
Benzopyrazone compounds, compositions thereof, and methods of treatment therewith
|
WO2004069152A2
(en)
|
2002-05-03 |
2004-08-19 |
Massachusetts Institute Of Technology |
Δ4,5 glycuronidase and uses thereof
|
US20040028685A1
(en)
|
2002-05-10 |
2004-02-12 |
Kinch Michael S. |
EphA2 monoclonal antibodies and methods of use thereof
|
CA2485548A1
(en)
|
2002-05-10 |
2004-02-19 |
Purdue Research Foundation |
Epha2 agonistic monoclonal antibodies and methods of use thereof
|
US20040087531A1
(en)
|
2002-05-16 |
2004-05-06 |
Adam Telerman |
Compositions and methods for the treatment of cancer
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
EP1578434A2
(en)
|
2002-07-09 |
2005-09-28 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
US20040072755A1
(en)
|
2002-07-12 |
2004-04-15 |
Stennicke Henning Ralf |
TF antagonist
|
US7521071B2
(en)
|
2002-10-09 |
2009-04-21 |
Versitech Limited |
Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
|
US7563810B2
(en)
|
2002-11-06 |
2009-07-21 |
Celgene Corporation |
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
|
MXPA05004780A
(es)
|
2002-11-06 |
2005-10-05 |
Celgene Corp |
Metodos y composiciones que usan farmacos inhibidores selectivos de citocina para el tratamiento y el manejo de canceres y otros padecimientos.
|
US7230012B2
(en)
|
2002-11-14 |
2007-06-12 |
Celgene Corporation |
Pharmaceutical compositions and dosage forms of thalidomide
|
BR0316256A
(pt)
|
2002-11-18 |
2005-10-04 |
Celgene Corp |
Métodos de inibir a produção de tnf-alfa e a atividade de pde4, de tratar ou prevenir uma doença ou um distúrbio, de controlar os nìveis de camp em uma célula e de produzir um composto, composição farmacêutica e composto
|
WO2004061113A1
(en)
|
2003-01-07 |
2004-07-22 |
The University Of Hong Kong |
Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
US20040146514A1
(en)
|
2003-01-21 |
2004-07-29 |
Smith James R. |
Cancer therapy using multiple antibodies from different species directed against the tumor3
|
WO2004065572A2
(en)
|
2003-01-23 |
2004-08-05 |
Molecular Engines Laboratories |
Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis
|
EP1622585A4
(en)
|
2003-05-02 |
2009-07-01 |
Aronex Pharmaceuticals Inc |
LIPID-PLATINUM COMPLEXES AND APPLICATION METHOD THEREFOR
|
CA2526278A1
(en)
|
2003-05-20 |
2004-12-02 |
Aronex Pharmaceuticals, Inc. |
Combination chemotherapy comprising a liposomal platinum complex
|
DE10351068B4
(de)
|
2003-10-30 |
2006-06-22 |
Hauni Maschinenbau Ag |
Staffeltrommel
|
LT2574341T
(lt)
|
2004-03-29 |
2017-09-11 |
University Of South Florida |
Navikų ir vėžio efektyvus gydymas triciribino fosfatu
|
US20100028339A1
(en)
|
2004-03-29 |
2010-02-04 |
Cheng Jin Q |
Compositions including triciribine and trastuzumab and methods of use thereof
|
WO2005110477A2
(en)
|
2004-04-09 |
2005-11-24 |
University Of South Florida |
Combination therapies for cancer and proliferative angiopathies
|